Exogenous sphingosine 1-phosphate (S1P) stimulated hydrogen peroxide (H 2 O 2 ) generation in association with an increase in intracellular Ca 2ϩ concentration in FRTL-5 thyroid cells. S1P also induced inositol phosphate production, reflecting activation of phospholipase C (PLC) in the cells. These three S1P-induced events were inhibited partially by pertussis toxin (PTX) and markedly by U73122, a PLC inhibitor, and were conversely potentiated by N 6 -(L-2-phenylisopropyl)adenosine, an A 1 -adenosine receptor agonist. In FRTL-5 cell membranes, S1P also activated PLC in the presence of guanosine 5Ј-O-(3-thiotriphosphate) (GTP␥S), but not in its absence. Guanosine 5Ј-O-(2-thiodiphosphate) inhibited the S1P-induced GTP␥S-dependent activation of the enzyme. To characterize the signaling pathways, especially receptors and G proteins involved in the S1P-induced responses, cross-desensitization experiments were performed. Under the conditions where homologous desensitization occurred in S1P-, lysophosphatidic acid (LPA)-, and bradykinin-induced induction of Ca 2ϩ mobilization, no detectable cross-desensitization of S1P and bradykinin was observed. This suggests that the primary action of S1P in its activation of the PLC-Ca 2ϩ system was not the activation of G proteins common to S1P and bradykinin, but the activation of a putative S1P receptor. On the other hand, there was a significant cross-desensitization of S1P and LPA; however, a still significant response to S1P (50 -80% of the response in the nontreated control cells) was observed depending on the lipid dose employed after a prior LPA challenge. S1P also inhibited cAMP accumulation in a PTXsensitive manner. We conclude that S1P stimulates H 2 O 2 generation through a PLC-Ca 2ϩ system and also inhibits adenylyl cyclase in FRTL-5 thyroid cells. The S1P-induced responses may be mediated partly through a putative lipid receptor that is coupled to both PTXsensitive and insensitive G proteins. (Endocrinology 138: 220 -229, 1997) S PHINGOSINE 1-phosphate (S1P), a phosphorylated product of sphingosine by sphingosine kinase, has recently been shown to be involved in the regulation of cellular processes including cell proliferation (1-4) and cell motility (5). The lysosphingolipid was first reported to directly act on the internal Ca 2ϩ pool, resulting in Ca 2ϩ mobilization in a way similar to inositol 1,4,5-trisphosphate (1, 6 -8). Intracellular S1P was accumulated in response to platelet-derived growth factor and serum in Swiss 3T3 fibroblasts (9). Thus, this lysosphingolipid has been proposed as a second messenger of platelet-derived growth factor and serum during cell proliferation (9). When intact Swiss 3T3 fibroblasts were exposed to S1P, this lipid induced an increase in the cytoplasmic free Ca 2ϩ concentration ([Ca 2ϩ ] i ) and the production of inositol trisphosphate (IP 3 ); however, the [Ca 2ϩ ] i increase occurred independent of the IP 3 production (8). In this case, S1P might penetrate the cells and induce the Ca 2ϩ mobilization through a direct interaction of the lipid with the Ca 2ϩ pool. In HL-60 cells, however, S1P increased [Ca 2ϩ ] i strictly depending on phospholipase C (PLC) activation and subsequent production of IP 3 (10). Thus, there are at least two possible mechanisms by which exogenous S1P can induce the Ca 2ϩ mobilization; the direct mechanism through its interaction with the Ca 2ϩ pool and the indirect one through PLC-catalyzed IP 3 production.
lysophosphatidic acid (LPA)-, and bradykinin-induced induction of Ca 2ϩ mobilization, no detectable cross-desensitization of S1P and bradykinin was observed. This suggests that the primary action of S1P in its activation of the PLC-Ca 2ϩ system was not the activation of G proteins common to S1P and bradykinin, but the activation of a putative S1P receptor. On the other hand, there was a significant cross-desensitization of S1P and LPA; however, a still significant response to S1P (50 -80% of the response in the nontreated control cells) was observed depending on the lipid dose employed after a prior LPA challenge. S1P also inhibited cAMP accumulation in a PTXsensitive manner. We conclude that S1P stimulates H 2 O 2 generation through a PLC-Ca 2ϩ system and also inhibits adenylyl cyclase in FRTL-5 thyroid cells. The S1P-induced responses may be mediated partly through a putative lipid receptor that is coupled to both PTXsensitive and insensitive G proteins. (Endocrinology 138: 220 -229, 1997) S PHINGOSINE 1-phosphate (S1P), a phosphorylated product of sphingosine by sphingosine kinase, has recently been shown to be involved in the regulation of cellular processes including cell proliferation (1) (2) (3) (4) and cell motility (5) . The lysosphingolipid was first reported to directly act on the internal Ca 2ϩ pool, resulting in Ca 2ϩ mobilization in a way similar to inositol 1,4,5-trisphosphate (1, 6 -8) . Intracellular S1P was accumulated in response to platelet-derived growth factor and serum in Swiss 3T3 fibroblasts (9) . Thus, this lysosphingolipid has been proposed as a second messenger of platelet-derived growth factor and serum during cell proliferation (9) . When intact Swiss 3T3 fibroblasts were exposed to S1P, this lipid induced an increase in the cytoplasmic free Ca 2ϩ concentration ([Ca 2ϩ ] i ) and the production of inositol trisphosphate (IP 3 ); however, the [Ca 2ϩ ] i increase occurred independent of the IP 3 production (8) . In this case, S1P might penetrate the cells and induce the Ca 2ϩ mobilization through a direct interaction of the lipid with the Ca 2ϩ pool. In HL-60 cells, however, S1P increased [Ca 2ϩ ] i strictly depending on phospholipase C (PLC) activation and subsequent production of IP 3 (10) . Thus, there are at least two possible mechanisms by which exogenous S1P can induce the Ca 2ϩ mobilization; the direct mechanism through its interaction with the Ca 2ϩ pool and the indirect one through PLC-catalyzed IP 3 production.
In thyroid cells, hydrogen peroxide (H 2 O 2 ) generation is an important process in thyroid hormone synthesis (11) . A number of studies have shown that receptor agonists (such as TSH and P 2 -purinergic receptor agonists) and also Ca 2ϩ -mobilizing agents (such as Ca 2ϩ ionophore and thapsigargin) stimulated H 2 O 2 generation depending on [Ca 2ϩ ] i in thyroid cells, including FRTL-5 cells (12) (13) (14) (15) . Thus, agents that increase [Ca 2ϩ ] i can be expected to induce H 2 O 2 generation in the cells. In the previous studies, the effects of S1P on cell functions other than cell proliferation and cell motility have not been well characterized. In the present report, therefore, we examined the effect of S1P on H 2 O 2 generation and its regulatory mechanism, especially focusing on the lipid-induced Ca 2ϩ -mobilizing mechanism in FRTL-5 thyroid cells. We found that exogenous S1P stimulated H 2 O 2 generation in the mediation of Ca 2ϩ indirectly mobilized through PLCcatalyzed IP 3 production rather than Ca 2ϩ mobilized by a direct interaction of S1P with the intracellular Ca 2ϩ pool. We further examined the early signaling mechanisms of S1P in both intact cells and a cell-free system. Our results suggest that S1P interacts with GTP-binding protein (G protein)-coupled receptors, resulting not only in activation of PLC but also inhibition of adenylyl cyclase.
Materials and Methods Materials
N 6 -(l-2-Phenylisopropyl)adenosine (PIA), adenosine deaminase, TSH, 3-isobutyl-1-methylxanthine, sphingosylphosphorylcholine (SPC), bradykinin, and 1-oleoyl-sn-glycero-3-phosphate (lysophosphatidic acid or LPA) were purchased from Sigma Chemical Co. (St. Louis, MO); guanosine 5Ј-O-(3-thiotriphosphate) (GTP␥S) and 5Ј-O-(2-thiodiphosphate) (GDP␤S) were obtained from Boehringer Mannheim (Indianapolis, IN); fura-2/AM was purchased from Dojindo (Tokyo, Japan); and myo- [2- 3 H]inositol (23.0 Ci/mmol) was obtained from DuPont-New England Nuclear (Boston, MA). S1P was prepared by treatment of SPC with phospholipase D as previously described (10) . Pertussis toxin (PTX) was generously provided by Dr. M. Ui of the Institute of Physical and Chemical Research (RIKEN, Wako, Japan), and U73122 and U73343 were purchased from Upjohn Co. (Kalamazoo, MI). For the RIA of cAMP, a Yamasa cAMP assay kit was used, which was a gift from Yamasa Shoyu Co. (Choshi, Chiba, Japan). The sources of all other reagents were described previously (10, (15) (16) (17) (18) (19) (15, (17) (18) (19) . In some experiments, for measurement of H 2 O 2 ( Fig. 3C ), cells were also cultured on 10-cm dishes. When the cells had become 90% confluent, the culture medium was changed to the fresh medium containing 5% calf serum and 5H (without TSH), and the cells were cultured for another 24 h for measurements of H 2 O 2 , cAMP, and [Ca 2ϩ ] i . For inositol phosphate response in intact cells and PLC assay in cell-free system, the culture medium was changed to the inositol-free DMEM medium (Life Technologies) containing 5% calf serum, 5H (without TSH), and [ 3 H]inositol (2.5 Ci/ml), and the cells were cultured for another 24 h. Where indicated, PTX (50 ng/ml) was added to the medium 24 h before the experiments.
Measurements of [Ca 2ϩ ] i and inositol polyphosphate production
The cells ([ 3 H]inositol-labeled cells in the case of inositol phosphate response) were washed twice with Ca 2ϩ -and Mg 2ϩ -free PBS containing 1 mm EGTA, then warmed in the same medium for about 10 min at 37 C. The cells were gently harvested from the dishes with a rubber policeman, then centrifuged at 250 ϫ g, and finally resuspended with Ham's F-10 medium containing 0.1% BSA, 5% calf serum, and 20 mm HEPES (pH 7.4). The cell suspensions were incubated in the presence of 1 m fura-2/AM (or in its absence in the case of inositol phosphate response) in the same medium for 20 min. The cells were washed twice by repeating the sedimentation at 250 ϫ g and resuspension with the HEPES-buffered medium, then finally resuspended with the same medium. The HEPES-buffered medium was composed of 20 ] i was estimated from the change in the fluorescence of the fura-2-loaded cells, as described previously (17, 18) . To determine the inositol phosphate response, the [ 3 H]inositol-labeled cell suspensions were preincubated for 10 min at 37 C in the presence of 10 mm LiCl and 0.5 U/ml adenosine deaminase; then test agents (10-fold concentrated) were added to the medium. In some experiments, shown in Fig.  3A , 2 min before addition of the test agents, U73122, U73343, or its vehicle [dimethylsulfoxide (DMSO)] was added to the incubation medium. For termination of the reaction, the cell suspensions (0.5 ml) were transferred to the tube containing 1 ml CHCl 3 -methanol-HCl (100:100:1 3 were separated on Dowex 1x8 formate columns as previously described (17, 18) . The radioactivity of the trichloroacetic acid (5%)-insoluble fraction was measured as the total radioactivity incorporated into the cellular inositol lipids (17, 18) . Where indicated, the results were normalized to 10 5 dpm of the total radioactivity.
Measurement of H 2 O 2 generation
H 2 O 2 generation was measured as previously described (14, 15) . In brief, the cells on 12-well plates were washed once with the HEPESbuffered medium and preincubated for 10 min at 37 C with the same medium. The medium was replaced with fresh medium containing the reaction mixture for measurement of H 2 O 2 generation (42 g/ml homovanillic acid, 25 g/ml peroxidase, and 0.5 U/ml adenosine deaminase) and the agents to be tested, and the cells were then incubated for 10 min. The medium was sucked off, and its fluorescence was measured with the excitation wavelength at 315 nm and the emission wavelength at 425 nm. In preliminary experiments, we found that U73122, a PLC inhibitor, was effective in cell suspensions, but not in the cells touching the plates. This peculiar observation might reflect a difference in the efficiency of uptake of the agent into the cells. Therefore, in the experiments shown in Fig. 3C , the cells cultured on 10-cm dishes were harvested and treated as described for measurements of [Ca 2ϩ ] i and inositol phosphate production. The cell suspensions were then preincubated at 37 C for the first 8 min with the HEPES-buffered medium and for another 2 min with the same medium containing the reaction mixture for measurement of H 2 O 2 generation in the presence of U73122, U73343, or DMSO. S1P was added to the medium, and the cells were incubated for an additional 10 min. Other experimental conditions were described previously (15) .
Measurement of cAMP content
The cells were washed once with HEPES-buffered medium, then preincubated for 10 min at 37 C with the same medium. The medium was replaced with fresh medium containing adenosine deaminase (0.5 U/ml), 3-isobutyl-1-methylxanthine (100 m), TSH (10 nm), and the indicated dose of S1P, and the cells were incubated for 10 min at 37 C. Termination of the reaction and measurement of cAMP content were performed as previously described (18) .
Membrane preparation and assay of PLC
The membranes were prepared from the [ 3 H]inositol-labeled cells, and the PLC assay was performed as previously described (19) . The data were normalized to 10 5 dpm of the radioactivity in membranes.
Data presentation
All experiments were performed in duplicate or triplicate. The results of multiple observations are presented as the mean Ϯ se or as representative results from more than three different batches of cells unless otherwise stated. Figure 1A shows a dose-dependent effect of S1P on H 2 O 2 generation in FRTL-5 thyroid cells. Because of the insolubility of S1P at higher doses, we could not examine the effect of more than 30 m S1P in the present study. S1P significantly stimulated H 2 O 2 generation at the minimal dose of 0.03 m. The effect of PTX on the S1P-induced response was also examined in this figure. PTX treatment was ineffective in the response to S1P at doses lower than 10 m, whereas the toxin slightly, but significantly, inhibited the response to a higher dose (30 m ] i followed by a sustained increase at the level of about 50% of the peak value (Fig. 1B) . In PTX-treated cells, the peak value was slightly lower than that of control cells not treated with the toxin (Fig. 1B) . The potency of S1P for the Ca 2ϩ response (increment of peak level from basal level) was comparable with that for the H 2 O 2 response. Furthermore, consistent with the H 2 O 2 response, PTX hardly affected the response to the lower dose of S1P, but significantly inhibited the response to a higher dose of the lipid, although the threshold of S1P for the inhibition by the toxin was slightly lower in the Ca 2ϩ response (ϳ3 m) than the H 2 O 2 response (30 m). This difference in the threshold of PTX effect may reflect the difference in the time when the S1P-induced responses were measured, i.e. at 10 min for the H 2 O 2 response and at about 30 sec for the Ca 2ϩ response. In Fig. 2 , we examined the S1P effect on inositol polyphosphate production. S1P clearly increased it in a time ( Fig. 2A )-and dose (Fig. 2B )-dependent manner, although more than 3 m S1P was necessary for a significant production. In this case as well, the PTX effect depended on the S1P dose employed; the response to the lower dose (3 m) was insensitive, Normalized basal values were 520 Ϯ 60 dpm for control cells and 609 Ϯ 36 dpm for PTX-treated cells, respectively. Data are the mean Ϯ SE of three separate experiments for both control and PTX-treated cells. Asterisks indicate that the effect of PTX is significant (*, P Ͻ 0.05; **, P Ͻ 0.01).
Results

Exogenous S1P stimulates H 2 O 2 generation in association with PLC activation and [Ca 2ϩ ] i increase
but those to higher doses (10 -30 m) were sensitive to the toxin.
S1P-induced [Ca 2ϩ ] i increase and H 2 O 2 generation are dependent on PLC activity
Thus, S1P stimulated H 2 O 2 generation and increased [Ca 2ϩ ] i and inositol polyphosphate production in parallel in a dose-dependent manner. This suggests that S1P-induced stimulation of PLC-catalyzed production of IP 3 may be responsible for mobilization of Ca 2ϩ and subsequent H 2 O 2 generation. To further confirm this point, we performed the following two kinds of experiments. Firstly, we examined the effects of PLC inhibitor on the S1P-induced responses (Fig.  3) . As expected, the S1P-induced inositol polyphosphate production was markedly inhibited by U73122, a PLC inhibitor (Fig. 3A) . In parallel with the inositol phosphate response, the S1P-induced increases in [Ca 2ϩ ] i ( Fig. 3B ) and H 2 O 2 generation ( Fig. 3C) were markedly inhibited by this enzyme inhibitor. U73343, an inactive derivative of U73122 for the enzyme, was ineffective on all of these responses, suggesting the specific effect of the inhibitor (Fig. 3) .
Secondly, we examined the effect of an A 1 -adenosine receptor agonist on the S1P-induced responses. We have previously shown that A 1 -agonists, through PTX-sensitive G i /G o proteins, can enhance the PLC activation and subsequent Ca 2ϩ mobilization induced by Ca 2ϩ -mobilizing receptor agonists, including ␣ 1 -adrenergic agonists (21), TSH (22) , and P 2 -purinergic agonists (18, 23) . Even though PIA alone hardly affected inositol polyphosphate production, the adenosine analog significantly enhanced the S1P-induced response (Fig. 4A) . The enhancement of the PLC response was accompanied by enhancement of the Ca 2ϩ response (Fig. 4C ) and the H 2 O 2 response (Fig. 4E) . Thus, PIA, which alone exerted only a small effect, synergistically or permissively increased the S1P-induced responses. In accordance with the cases of A 1 -agonist effects on other Ca 2ϩ -mobilizing agonistinduced actions (21) (22) (23) , PIA-induced responses in collaboration with S1P were completely inhibited by prior treatment of the cells with PTX (Fig. 4, B 
S1P not only activates PLC but also inhibits adenylyl cyclase through a G protein-dependent mechanism
As shown in Fig. 2 , S1P-induced activation of PLC was partially inhibited by PTX treatment, suggesting that G i /G o proteins are somehow involved in the lipid signaling. If G i /G o proteins are involved in the S1P signaling, one can expect that the lipid may also affect other G i /G o proteinmediated responses. Here, we examined the S1P effect on cAMP accumulation. As shown in Fig. 5 , S1P, in a dosedependent manner, inhibited TSH-induced cAMP accumulation. In this experiment, because 3-isobutyl-1-methylxanthine, a potent phosphodiesterase inhibitor, was included in the incubation medium, a change in the cAMP content may, therefore, reflect adenylyl cyclase activity. As expected, PTX treatment of the cells almost completely suppressed the S1P-induced inhibition of cAMP accumulation (Fig. 5) .
To further clarify the mechanism underlying S1P-induced activation of PLC, we analyzed the enzyme activity in mem- brane fractions prepared from FRTL-5 cells (Fig. 6) . S1P was effective in the presence of GTP␥S, a hydrolysis-resistant derivative of GTP, but was ineffective in its absence; the lipid significantly enhanced GTP␥S-induced activation of the enzyme (Fig. 6A) . The enhancement by S1P of the enzyme activity was dependent on the concentration of GTP␥S employed; S1P potentiated the action of GTP␥S at lower doses of the nucleotide, but not at the maximally effective dose of GTP␥S (Fig. 6B) . Thus, S1P increased the apparent affinity for GTP␥S to activate the enzyme. The same guanine nucleotide dependency was observed for other Ca 2ϩ -mobilizing agonist-induced enzyme activations in FRTL-5 cells (19) and in other cell membrane preparations (24) . This phenomenon has been recognized in such a way that a receptor ligand induces coupling of its receptor to G proteins and thereby accelerates the exchange of GDP with GTP (or GTP␥S) on the G protein molecules (24, 25) . Thus, S1P seems to activate the enzyme through a G protein-mediated mechanism. The involvement of G proteins in the S1P-induced activation of the enzyme was further supported by the observation that GDP␤S almost completely inhibited S1P-induced GTP␥S-dependent enzyme activation (Fig. 6A) .
The dose-dependent effect of S1P on the enzyme activity is shown in Fig. 6C . S1P alone did not exert any effect at least up to 30 m, but the lipid did activate the enzyme in the presence of GTP␥S with a potency similar to that in intact cells (Fig. 2B) . The enzyme activity was also examined in the membranes prepared from PTX-treated cells; the toxin treatment hardly affected the basal activity or GTP␥S-and S1P-induced enzyme activation (Fig. 6C) . 
No cross-desensitization of S1P and bradykinin for induction of Ca 2ϩ mobilization
The foregoing results clearly suggested the involvement of some G proteins in the S1P signaling pathways. However, it is still unclear whether S1P activates these G proteins directly or indirectly through receptors as do other G protein-coupled receptor agonists. To clarify this point, we examined the cross-desensitization of bradykinin, whose receptor is known to couple to G proteins, and S1P for induction of Ca 2ϩ mobilization (Fig. 7) . To eliminate the possible involvement FIG. 6. Guanine nucleotide-dependent S1P-induced activation of PLC in membrane preparations. In A, the 3 H-labeled membranes were incubated with the indicated dose of S1P and/or GTP␥S in the presence or absence of GDP␤S. Data are the mean Ϯ SE of three separate experiments. **, Effect of S1P is significant (P Ͻ 0.01). In B, the 3 H-labeled membranes were incubated with the indicated doses of GTP␥S in the presence (q) or absence (E) of S1P (10 M). Data are the mean Ϯ SE of three separate experiments. Asterisks indicate that the effect of S1P is significant (*, P Ͻ 0.05; **, P Ͻ 0.01). In C, the ] i . Thus, S1P-and bradykinin-induced Ca 2ϩ mobilization were homologously desensitized. Under these conditions, there was no crossdesensitization of S1P and bradykinin for induction of the Ca 2ϩ response; the response to either S1P or bradykinin after a bradykinin challenge or a S1P challenge was unchanged compared with the respective control response (Fig. 7) .
S1P induces Ca 2ϩ mobilization at least partly through an LPA receptor-independent mechanism
In FRTL-5 cells, LPA was also effective in increasing [Ca 2ϩ ] i . This LPA-induced [Ca 2ϩ ] i increase was markedly inhibited by prior treatment of the cells with PTX (Fig. 8A ) and was almost completely by U73122 (data not shown), suggesting mediation through a G protein-regulated PLC activation. To examine the possible involvement of a LPA receptor in the S1P-induced Ca 2ϩ response, cross-desensitization experiments were performed. In these experiments as well, PTX-treated cells were used to eliminate the involvement of G i /G o protein-induced permissive stimulation of the PLC-Ca 2ϩ system. When the cells were pretreated with S1P, the Ca 2ϩ responses to LPA (Fig. 8 , B and C) as well as those to S1P (see Fig. 7 ) were markedly inhibited. Similarly, the effects of LPA and S1P were inhibited after a LPA challenge (Fig. 8, B and C) . In the case of LPA, its effect was markedly inhibited. However, in the case of S1P, only 20 -50% of the effect was inhibited depending on the S1P dose employed; if the lipid dose was increased, the inhibition rate increased (Fig. 8, B and C) . Under these conditions, the bradykinininduced action was unchanged after a prior challenge with either S1P (Fig. 7) or LPA (data not shown), indicating that the loss of the response was not due to the depletion of Ca 2ϩ in the pool.
Discussion
As mentioned in the introduction, direct interaction of S1P with the internal Ca 2ϩ pool, possibly with the lipid-gated Ca 2ϩ channel, has been suggested as a mechanism of S1P-induced Ca 2ϩ mobilization (6 -8) . In fact, in intact Swiss 3T3 fibroblasts, exogenous S1P induced Ca 2ϩ mobilization through an IP 3 -independent mechanism even though the lipid activates PLC and produces IP 3 in the cells (8) . In the present report, however, we showed that S1P increased [Ca 2ϩ ] i totally depending on PLC-catalyzed production of IP 3 , resulting in stimulation of H 2 O 2 generation, an important event in thyroid hormone synthesis in FRTL-5 thyroid cells. This was based on the following observations. Firstly, S1P-induced H 2 O 2 generation and Ca 2ϩ mobilization were inhibited by U73122, a PLC inhibitor, in association with inhibition of PLC activity. Secondly, enhancement of the S1P-induced PLC activation by PIA, an adenosine derivative, was ] i (the peak value Ϫ the basal value) are shown. Results are the mean Ϯ SE of at least five separate experiments for both control and PTX-treated cells. A significant LPA effect was observed at all points examined (from 0.1-10 M). The effects of PTX were significant (*, P Ͻ 0.05; **, P Ͻ 0.01). In B and C, cross-desensitization experiments were performed in PTXtreated cells. In B, at the arrow, the indicated dose in parentheses (micromolar concentration) of LPA or S1P was applied to monitor the change in [Ca 2ϩ ] i . In C, increments in [Ca 2ϩ ] i (peak value Ϫ basal value) by the indicated doses in parentheses (micromolar concentration) of S1P or LPA in the cells pretreated with 10 M LPA or 10 M S1P are expressed as percentages of the respective control values without pretreatment with these agents. These control values were 49 Ϯ 12, 70 Ϯ 4, 203 Ϯ 18, and 107 Ϯ 6 nM for 0.1 M S1P, 1 M S1P, 10 M S1P, and 10 M LPA, respectively. Results are representatives for B and the mean Ϯ SE for C of at lease four separate experiments.
accompanied by enhancement of Ca 2ϩ and H 2 O 2 responses to the lipid. Finally, S1P-induced PLC activation and PIAinduced enhancement of the lipid-induced action were inhibited partially and completely, respectively, by PTX treatment. In parallel with the PLC response, Ca 2ϩ and H 2 O 2 responses to S1P and those to PIA in collaboration with S1P were also inhibited partially and completely, respectively, by the toxin treatment. In HL-60 leukocytes as well, we have shown that exogenous S1P induced Ca 2ϩ mobilization through IP 3 production rather than through direct interaction with the Ca 2ϩ pool (10) . Preliminary experiments with rat hepatocytes also showed that the S1P-induced [Ca 2ϩ ] i increase was dependent on the PLC activation. Thus, the Ca 2ϩ mobilization through PLC-catalyzed IP 3 production by S1P is not necessarily restricted to specific cell types.
G Proteins have been assumed to be involved in the S1P-induced activation of PLC based on PTX sensitivity in the previous studies; the toxin treatment of cells markedly inhibited lipid-induced enzyme activation in 3T3 fibroblasts (3) and HL-60 cells (10) . However, in the previous studies, there was no evidence showing that guanine nucleotides actually regulate the lipid-induced enzyme activation. In the present study, we demonstrated for the first time that the lipidinduced activation of the enzyme is guanine nucleotide dependent in the membrane preparations of FRTL-5 cells. S1P-induced guanine nucleotide-dependent activation of PLC in a cell-free system was totally independent of PTX at any dose of S1P employed, suggesting that lipid-induced enzyme activation may be mediated by PTX-insensitive G proteins.
Consistent with the results in a cell-free system, S1P-induced actions on PLC and its cascade reactions at lower doses (Ͻ3 m) were hardly affected by PTX treatment in intact cells; however, those at higher doses (Ͼ10 m) were partly, but significantly, inhibited by the toxin treatment. The reversal of S1P-induced inhibition of cAMP accumulation by PTX treatment suggests that the partial inhibition of PLC activation by the toxin may not be due to incomplete ADP ribosylation of G i /G o proteins by the toxin. In fact, [ 32 P]ADP ribosylation of G i /G o proteins by PTX of the membrane prepared from the cells pretreated with the toxin in a similar way to the present experiments was almost completely lost, reflecting the consumption of PTX substrate proteins by prior exposure of the cells to the toxin (17) . Complete ADP ribosylation of G i /G o proteins was also supported by the finding that PIA-induced responses in collaboration with S1P were completely inhibited by the same treatment of the cells with the toxin. Furthermore, increasing the PTX dose from 50 ng/ml to 1 g/ml never elevated the rate of the inhibition of S1P-induced Ca 2ϩ response (data not shown). These results suggest the involvement of a PTX-insensitive mechanism as well as a toxin-sensitive one in S1P-induced PLC activation.
We cannot explain clearly the discrepancy in the results between intact cells and cell-free systems with respect to PTX sensitivity; however, we observed similar phenomena in A 1 -adenosine receptor-induced activation of PLC. Adenosine or A 1 -receptor agonists, although they have a very low or undetectable effect on PLC activity, markedly enhanced the enzyme activation induced by Ca 2ϩ -mobilizing agonists such as ␣ 1 -adrenergic agonists (21), TSH (22), and P 2 -purinergic agonists (18, 23) in intact FRTL-5 cells. The A 1 -agonistinduced actions were completely suppressed by PTX treatment (18, (21) (22) (23) . Thus, A 1 -receptor-mediated activation of PLC is detected only when Ca 2ϩ -mobilizing agonists coexist. In a cell-free system, however, the PTX-sensitive A 1 -receptor agonist-induced PLC activation was not detected, whereas the PTX-insensitive Ca 2ϩ -mobilizing agonist-induced enzyme activation was clearly detected (19) . This suggests that in our FRTL-5 thyroid cell-free system, the indirect or permissive stimulation of the enzyme through G i /G o proteins cannot be detected. This also suggests that S1P-induced activation of PLC at higher doses involves such an indirect or permissive activation by G i /G o proteins of the enzyme. The activation of G i /G o proteins by S1P was suggested based on the finding that S1P at higher doses of more than 10 m inhibited cAMP accumulation, probably reflecting the inhibition of adenylyl cyclase, in a PTX-sensitive manner. If S1P, like PIA, has the ability to activate G i /G o proteins, one might wonder why PIA could enhance S1P-induced PLC activation. The ability of S1P to activate G i /G o proteins is much less than that of A 1 -agonists, as evidenced by only about 50% inhibition by S1P vs. more than 95% inhibition by PIA (18, 22) of TSH-induced cAMP accumulation. This discrepancy may explain why PIA can enhance S1P-induced activation of PLC and its cascade reactions. Although further experiments are required to understand more precisely the mechanism underlying S1P-induced activation of PLC, especially regarding the species of G proteins involved and their roles in enzyme activation, the results of the present study suggested that at least two types of G proteins may be involved in the S1P signaling in FRTL-5 cells.
In addition to PLC activation, S1P has recently been reported to influence effector systems, such as adenylyl cyclase (3, 26) , K ϩ channel (26, 27) , and mitogen-activated protein kinase (4) , that are involved in the early signal transduction of cell surface receptor agonists. Similar stimulation of these effector systems has been reported by lysosphingolipids other than S1P, such as SPC and psychosine (16, 26, 28 -30) . As mentioned above, we found that S1P induced inhibition of adenylyl cyclase in addition to PLC activation in FRTL-5 cells. In this case, PTX almost completely suppressed the S1P-induced action. Thus, S1P stimulated at least two signaling pathways, leading to activation of PLC and inhibition of adenylyl cyclase, probably through distinct G proteins in FRTL-5 thyroid cells, i.e. the former pathway may be mediated predominantly through PTX-insensitive G proteins such as G q /G 11 , and the latter pathway through PTX-sensitive G proteins such as G i /G o proteins. G i /G o proteins may also be involved in the activation of PLC in an indirect or permissive manner.
The involvement of G proteins in S1P signaling pathways raises the possibility of the existence of G protein-coupled receptors for the lipid. In fact, although no direct evidence has been presented, cell surface receptors for S1P have recently been proposed in Xenopus oocytes (30) , HL-60 cells (10) , and HEK293 cells (26) . Bradykinin activates PLC through PTX-insensitive G proteins, probably G q /G 11 proteins (31) . In FRTL-5 cells as well, the bradykinin-induced [Ca 2ϩ ] i increase was insensitive to PTX, suggesting an involvement of G q /G 11 proteins in the PLC-Ca 2ϩ system, al-though the possibility cannot be ruled out that S1P and bradykinin act through a different G q /G 11 family of proteins. Lack of cross-desensitization between S1P and bradykinin in the induction of Ca 2ϩ mobilization in FRTL-5 cells suggests that S1P-induced desensitization seems to occur at the level before G protein in the lipid signaling. In our preliminary experiments, we found that S1P did not significantly activate the PLC-Ca 2ϩ system in either PC12 cells or GH 3 cells, in which G q /G 11 proteins are demonstrated to be involved in the receptor-mediated PLC activation (32, 33) . This also supports the idea that G q /G 11 proteins may not be the site of S1P. These results imply the existence of the putative receptor as a primary action site of S1P. To conclude the existence of the putative S1P receptor, however, S1P binding experiments or receptor cloning studies are necessary.
In relation to the putative S1P receptor, it has also been proposed that S1P acts through a recently identified receptor for LPA, one of the lysoglycerolipids, which has a chemical structure similar to that of S1P, in some cell types (34, 35) . In FRTL-5 cells, LPA also increased [Ca 2ϩ ] i and induced H 2 O 2 generation (data not shown); however, in this case, the toxin treatment markedly (70 -80%; in the case of S1P, this value was at most ϳ50%) suppressed these LPA-induced responses. Furthermore, under conditions where the LPA-induced [Ca 2ϩ ] i increase was almost completely desensitized, S1P was still effective in increasing [Ca 2ϩ ] i depending on the concentration of S1P employed, suggesting that S1P acts at least partly through a LPA receptor-independent mechanism, although S1P and LPA may in part share the same receptor, as evidenced from the partial cross-desensitization of these lipids. The inhibition rate of the S1P-induced response after a LPA challenge increased as the dose of S1P increased. This suggests that S1P may interact preferentially with a S1P-specific receptor at the lower dose, but if the dose of S1P is increased, the lipid may interact with, in addition to the S1P specific receptor, a LPA receptor or a similar receptor whose signaling pathway converges with that of the LPA receptor.
At present, we cannot present evidence showing that extracellular S1P induces in vivo the thyroid functional responses observed in the present study. However, a recent study showed that S1P can be released from platelets into the extracellular medium in response to physiological agonists such as thrombin (36) ; about 5% of S1P in platelets (1.42 nmol/10 9 platelets) could be released in response to agonists. If this occurs in extracellular environment of thyroid cells in vivo, the concentration of S1P would reach about 20 nm; this value (nanomoles per liter) was estimated as the following equation, 0.05 ϫ (1.42/10 9 ) ϫ (3 ϫ 10 11 ), where the amount of platelets in blood was assumed to be 3 ϫ 10 11 platelets/ liter (37) . A minimum effective doses of S1P to induce a [Ca 2ϩ ] i increase and H 2 O 2 generation in the present study was about 30 nm, which is not very different from the concentration estimated under conditions where platelets are activated. S1P is a form of sphingosine phosphorylated by sphingosine kinase. Because sphingosine and the enzyme seem to be distributed in many types of cells and tissues (38) , we can also imagine that S1P is produced in thyroid cells and released outside the cells as an autocrine factor. This hypothesis is our next project of investigation.
In conclusion, in FRTL-5 thyroid cells, exogenous S1P can induce H 2 O 2 generation, a pivotal process for expression of thyroid functions, probably through IP 3 -dependent Ca 2ϩ mobilization. S1P not only activates PLC, resulting in the production of IP 3 , but also inhibits adenylyl cyclase, resulting in a decrease in the cAMP content. The S1P-induced stimulation of the signaling pathways may be mediated through a receptor(s) coupling to G proteins. Thus, in addition to the second messenger role inside the cells, S1P seems to affect cellular functions, such as the lipid mediators PGs and leukotrienes, from outside the cells.
